Tradingcurrent (@tradingcurrent) 's Twitter Profile
Tradingcurrent

@tradingcurrent

🇨🇴

ID: 3236369166

calendar_today04-06-2015 22:20:02

1,1K Tweet

206 Followers

703 Following

Tradingcurrent (@tradingcurrent) 's Twitter Profile Photo

$HIMS I mean to be fair at $13b market cap they’re still cheap. If they capture a decent size of the GLP-1 market, it’s going to bring in so much cash

Tradingcurrent (@tradingcurrent) 's Twitter Profile Photo

$SPY $NVDA $PLTR should block the people who were fear mongering like 2 or 3 weeks ago about how we were going to see the biggest stock market crash

Tradingcurrent (@tradingcurrent) 's Twitter Profile Photo

$AMD is the closest company to $NVDA one is about ~$200b market cap and the other is $3.2t market cap. As they become more more competitive, it’s only going to close the gap, it will happen. I’m long.

Tradingcurrent (@tradingcurrent) 's Twitter Profile Photo

Is the Middle East becoming the powerhouse for the AI revolution? Unlike the United States who changes political leaders every 4 years which can lower priority to AI, can result in a set back their lead position. Countries like Saudi Arabi, Qatar, and UAE leadership doesn’t

Tradingcurrent (@tradingcurrent) 's Twitter Profile Photo

$REGN they have ~$15 billion in cash. The investment in $ME for $256m is a drop in the bucket for a huge data set. This is bullish

Tradingcurrent (@tradingcurrent) 's Twitter Profile Photo

$MRVL A turn around story, betting all the chips (literally) in AI data center infrastructure, and it's paying off. A growth store coupled with an undervalued price at Ev/Rev NTM 7x is a compelling investment opportunity. Excited to see their earnings next week, will be a "show

$MRVL A turn around story, betting all the chips (literally) in AI data center infrastructure, and it's paying off. A growth store coupled with an undervalued price at Ev/Rev NTM 7x is a compelling investment opportunity. Excited to see their earnings next week, will be a "show
Tradingcurrent (@tradingcurrent) 's Twitter Profile Photo

$TSLA Thank god I sold my Tesla position this morning. Investors were dumping over the past couple of days due to the rising rift between Trump and Elon. Now Elon just put the final nail in the coffin 😂 Will certainly be looking to get back in once the smoke clears.

Frank Slootman’s Abandoned Projects (@davey_juice) 's Twitter Profile Photo

Shoutout to the homies who loaded up $snow with me for long stretches of the past 3 long years… even up 79% on a 1 year time frame and 45% ytd… who knew $snow shareholders could see green on any timeframe,

Shoutout to the homies who loaded up $snow with me for long stretches of the past 3 long years… even up 79% on a 1 year time frame and 45% ytd… who knew $snow shareholders could see green on any timeframe,
Tradingcurrent (@tradingcurrent) 's Twitter Profile Photo

$MRNA The potential buyout parter has to be Merck $MRK due to their partnership in oncology pipeline treatments which will be the most important part of Moderna’s portfolio

Tradingcurrent (@tradingcurrent) 's Twitter Profile Photo

$MRNA It’s only the beginning. Moderna currently hit $15bn market cap which is severally undervalued to their future revenue potential with Merck.

$MRNA It’s only the beginning. Moderna currently hit $15bn market cap which is severally undervalued to their future revenue potential with Merck.
Mitch Jones (@mitchjonez) 's Twitter Profile Photo

$1k giveaway on this tweet - like, comment, retweet to enter $100k Bonus hunt Today on twitch then after i am doing a stream on the rainbet channel to give away $15000. Join at 6pm EST // 3pm PST kick.com/rainbet

Tradingcurrent (@tradingcurrent) 's Twitter Profile Photo

$MRNA So this guy Vinayak Prasad writes a RTF letter because he has a personal vendetta against mRNA vaccines. When other countries such as EU, Canada, Austrlia, etc.. all want and approve mRNA-1010 , it will just show his bias

Tradingcurrent (@tradingcurrent) 's Twitter Profile Photo

$XBI up 2% after hours on the announcement of Vinay Prasad's departure in April. Multiple individual biotech stocks up double digits after hours. This must tell you he wasn't very good, but bad for the biotech industry.